Phase II Study of Alternating Sunitinib and Temsirolimus
Dartmouth-Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
The University of Texas Health Science Center, Houston
Western Regional Medical Center
Dana-Farber Cancer Institute
St. Joseph's Healthcare Hamilton
University of Southern California
M.D. Anderson Cancer Center
Pfizer
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Leon Berard
Pfizer
Radboud University Medical Center
AVEO Pharmaceuticals, Inc.